Perceptive Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-250,000
Closed -$8.07M 114
2022
Q1
$8.07M Buy
+250,000
New +$6.55M 0.16% 88
2018
Q4
Sell
-110,000
Closed -$3.12M 107
2018
Q3
$3.12M Buy
110,000
+40,000
+57% +$954K 0.08% 78
2018
Q2
$1.47M Buy
+70,000
New +$1.32M 0.04% 91
2018
Q1
Sell
-50,000
Closed -$615K 146
2017
Q4
$615K Sell
50,000
-800,000
-94% -$11.3M 0.02% 115
2017
Q3
$15.1M Sell
850,000
-224,327
-21% -$4.62M 0.58% 43
2017
Q2
$27.2M Sell
1,074,327
-370,173
-26% -$8.9M 1.37% 20
2017
Q1
$32.2M Buy
1,444,500
+1,136,700
+369% +$21.8M 1.83% 16
2016
Q4
$4.55M Sell
307,800
-120,484
-28% -$2.37M 0.32% 59
2016
Q3
$10.5M Sell
428,284
-444,780
-51% -$10.4M 0.68% 37
2016
Q2
$16.8M Buy
873,064
+254,134
+41% +$3.49M 1.16% 22
2016
Q1
$6.54M Buy
618,930
+471,330
+319% +$4.87M 0.57% 47
2015
Q4
$1.79M Buy
147,600
+10,311
+8% +$152K 0.13% 77
2015
Q3
$2.19M Sell
137,289
-15,511
-10% -$303K 0.18% 77
2015
Q2
$2.98M Buy
+152,800
New +$2.85M 0.18% 83

Other funds holding EVH

Perceptive Advisors's EVH Position: Q2 2022 in Review

Perceptive Advisors sold out of Evolent Health (EVH) in Q2 2022, closing a stake of 250,000 shares — an estimated $8.07M sold.

Perceptive Advisors first reported a position in EVH in Q2 2015 and held it in 14 quarters. The position peaked at $32.2M in Q1 2017. 215 funds tracked by Wall St. Rank hold EVH as of Q2 2022.

  • Perceptive Advisors reported no remaining Evolent Health position as of Q2 2022 after selling out during the quarter.
  • Perceptive Advisors sold 250,000 Evolent Health shares in Q2 2022, an estimated $8.07M.
  • Perceptive Advisors first reported a position in Evolent Health in Q2 2015 and held it in 14 quarters.
  • Perceptive Advisors's Evolent Health position peaked at $32.2M in Q1 2017.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q2 2022.

Based on Perceptive Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.